Abstract
NF-κB regulates inflammatory and immune response by increasing the expression of specific genes. In celiac disease proinflammatory cytokines, adhesion molecules, and enzymes whose gene expression is known to be regulated by NF-κB are involved. This study investigated the activation of NF-κB in inflamed mucosa from patients with untreated celiac disease. Biopsy specimens from control, untreated, and treated patients were subjected to molecular biology analysis. NF-κB activation was evaluated by electrophoretic mobility shift assay. NF-κB related subunit protein level, and inducible nitric oxide synthase and cyclo-oxygenase 2 protein expression was analyzed by western blot. Both NF-κB/DNA binding activity and p50/p65 nuclear levels were higher in biopsy specimens from untreated patients than in those from treated patients and controls. The degradation of IκBβ in the cytosol and the reappearance in the nucleus indicated a persistent NF-κB activation in celiac disease. NF-κB activity was maintained in cultured biopsy specimens up to 6 h and decreased at 24 h, and then the addition of peptic-tryptic digest of gliadin caused the recovery of NF-κB activity at 6 h. NF-κB/DNA binding activity was correlated with inducible nitric oxide synthase and cyclo-oxygenase-2 protein expression. These results show for the first time that NF-κB is activated in the inflamed mucosa of celiac patients and suggest that it may represent a molecular target for the modulation of inflammatory response in celiac disease.
Similar content being viewed by others
Abbreviations
- CD :
-
Celiac disease
- COX :
-
Cyclo-oxygenase
- iNOS :
-
Inducible nitric oxide synthase
- IκB :
-
Inhibitory protein κB
- NF-κB :
-
Nuclear factor κB
- Pt-G :
-
Peptic-tryptic digest of gliadin
References
Sollid LM (2002) Celiac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2:647–655
Nilsen EM, Jahnsen FL, Lundin KEA, Johansen F-E, Fausa O, Sollid LM, Jahnsen J, Scott H, Brandtzaeg P (1998) Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 15:551–563
Przemioslo R, Kontakou M, Nobili V, Ciclitira P (1994) Raised pro-inflammatory cytokines interleukin 6 and tumor necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry. Gut 35:1398–1403
Sturgess R, Kontakou M, Spencer J, Hooper L, Makgoba M, Ciclitira PJ (1993) Effects of interferon-gamma and tumor necrosis factor-alpha on ICAM-1 expression on jejunal mucosal biopsies cultured in vitro. Gut 34:S31
Beckett CG, Dell'Olio D, Shidrawi RG, Rosen-Bronson S, Ciclitira PJ (1999) Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies. Eur J Gastroenterol Hepatol 11:529–535
Lavö B, Knutson L, Lööf L, Hällgren R (1990) Gliadin challenge-induced jejunal prostaglandin E2 secretion in celiac disease. Gastroenterology 99:703–707
Steege J ter, Buurman W, Arends JW, Forget P (1997) Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease. Lab Invest 77:29–36
Straaten EA van , Koster-Kamphuis L, Bovee-Oudenhoven IM, van der Meer R, Forget P-P (1999) Increased urinary nitric oxide oxidation products in children with active coeliac disease. Acta Paediatr 88:528–531
Kainulainen H, Rantala I, Collin P, Ruuska T, Päivärinne H, Halttunen T, Lindfors K, Kaukinen K, Mäki M (2002) Blisters in the small intestinal mucosa of coeliac patients contain T cells positive for cyclooxygenase-2. Gut 50:84–89
Xie Q, Kashiwabara Y, Nathan C (1994) Role of transcription factor NF-κB/Rel in induction of nitric oxide. J Biol Chem 269:4705–4708
Yamamoto K, Arakawa T, Ueda N, Yamamoto S (1995) Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3–E1 cells. J Biol Chem 270:31315–31320
Ghosh S, May MJ, Kopp EB (1998) NF-κB and REL proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225–260
Schmid RM, Adler G (2000) NFκB/Rel/IkB: implications in gastrointestinal disease. Gastroenterology 118:1208–1228
Picarelli A, Maiuri L, Frate A, Greco M, Auricchio S, Londei M (1996) Production of antiendomysial antibodies after in vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet 348:1065–1067
De Ritis G, Occorsio P, Auricchio S, Gramenzi F, Morisi G, Silano V (1979) Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus. Pediatr Res 13:1255–1261
D'Acquisto F, Ialenti A, Ianaro A, Di Vaio R, Carnuccio R (2001) Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw. Gene Ther 7:1731–1737
Bourke E, Kennedy EJ, Moynagh PN (2000) Loss of IκB-β is associated with prolonged NF-κB activity in human glial cells. J Biol Chem 275:39996–40002
Johnson DR, Douglas I, Jahnke A, Ghosh S, Pober JS (1996) A sustained reduction in IkappaB-beta may contribute to persistent NF-kappaB activation in human endothelial cells. J Biol Chem 271:16317–16322
DeLuca C, Petropoulos L, Zmeureanu D, Hiscott J (1999) Nuclear IκBβ maintains persistent NF-κB activation in HIV-1-infected myeloid cells. J Biol Chem 274:13010–13016
Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S (1995) IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573–582
Suyang H, Phillips RJ, Douglas I, Ghosh S (1996) Role of unphosphorylated, newly synthesized IκB-β in persistent activation of NF-κB. Mol Cell Biol 16:5444–5449
McKinsey TA, Chu ZL, Ballard DW (1997) Phosphorylation of the PEST domain of IkappaBbeta regulates the function of NFkappaB/IkappaBbeta complexes. J Biol Chem 272:22377–22380
McCafferty DM, Mudgett JS, Swain MG, Kubes P (1997) Inducible nitric oxide synthase plays acritical role in resolving intestinal inflammation. Gastroenterology 112:1022–1027
Grisham MB, Pavlick KP, Stephen Laroux F, Hoffman J, Bharwani S, Wolf RE (2002) Nitric oxide and chronic gut inflammation: controversies in inflammatory bowel disease. J Investig Med 50:272–283
Newberry RD, Stenson WF, Lorenz RG (1999) Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 5:900–906
Morteau O (1999) COX-2: promoting tolerance. Nat Med 8:867–868
Aronica MA, Mora AL, Mitchell DB, Finn PW, Johnson JE, Sheller JR, Boothby MR (1999) Preferential role for NF-κB/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol 163:5116–5124
Makarov SS (2000) NF-κB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 6:441–448
Nilsen EM, Lundin KEA, Krajci P, Scott H, Sollid LM, Brandtzag P (1995) Gluten specific, HLA-DQ restricted T cells from celiac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon-γ. Gut 37:766–776
Acknowledgements
This research was supported by a grant from the Italian government (PRIN 2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maiuri, M.C., De Stefano, D., Mele, G. et al. Nuclear factor κB is activated in small intestinal mucosa of celiac patients. J Mol Med 81, 373–379 (2003). https://doi.org/10.1007/s00109-003-0440-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-003-0440-0